| Canonical Pathwaysanuity Canonical Pathways |
pp-valueb |
| Inhibition of Angiogenesis by TSP1 (tumor suppressor region 1) |
1.73E00 |
| Mechanisms of Viral Exit from Host Cells |
1.25E00 |
| PKCθ (protein kinase C theta ) Signaling in T Lymphocytes |
8.05E-01 |
| Caveolar-mediated Endocytosis Signaling |
6.7E-01 |
| FcγRIIB (Fc receptor or CD32) Signaling in B Lymphocytes |
6.03E-01 |
| Phospholipase C Signaling |
4.97E-01 |
| RhoA (RhoA kinase) Signaling |
4.79E-01 |
| Complement System |
4.79E-01 |
| NRF2(nuclear factor erythroid 2) mediated Oxidative Stress Response |
4.36E-01 |
| Lipid Antigen Presentation by CD1 |
4.28E-01 |
| Role of JAK2 (Janus Kinase 2) in Hormone-like Cytokine Signaling |
4.18E-01 |
| Coagulation System |
3.63E-01 |
| Crosstalk between Dendritic Cells and Natural Killer Cells |
3.55E-01 |
| Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells |
3.34E-01 |
| Retinoic acid Mediated Apoptosis Signaling |
3.25E-01 |
| Endoplasmic Reticulum Stress Pathway |
2.99E-01 |
| Role of JAK1 (Janus Kinase 1), JAK2 and TYK2 (tyrosine kinase 2) in Interferon Signaling |
2.81E-01 |
